| Pierre Fabre Pharma SA - Braftovi 50 mg, Hartkapseln | | 66795 | | 01 | | Braftovi 50 mg | | Hartkapseln | | L01EC03 | | Encorafenib | | 01.11.2019 | | |
| | Composition | | encorafenibum 50 mg, copovidonum K 28, poloxamerum 188, cellulosum microcristallinum, acidum succinicum, crospovidonum, silica colloidalis anhydrica, magnesii stearas, Kapselhülle: gelatina, E 171, E 172 (rubrum), E 172 (flavum), E 172 (nigrum), Drucktinte: lacca, E 172 (nigrum), pro capsula. | | Packungsbestandteile | | Capsules | | | | | Principe actif | Concentr. |
|---|
| Encorafenibum | 50 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Encorafenibum | 50 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Flavum) | | | | (Nigrum) | | | | (Rubrum) | | | | Acide Succinique | | | | Cellulosum Microcristallinum | | | | Copovidonum K | 28 | | | Crospovidonum | | | | E 171 | | color. | | E 172 | | color. | | Gelatina | | Kapselhülle | | Lacca | | Drucktinte | | Magnesii Stearas | | | | Poloxamer | 188 | | | Pro Capsula | | | | Silica Colloidalis Anhydrica | | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 28 | 563.97 | 629.75 | A | LS | Non | | 003 | 112 | | | A | | Oui |
|
|
